Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 6, 2007, Pages 534-539

  Dao, Nguyen Van Hoang ^a   Cuong, Bui Tri ^b   Ngoa, Nguyen Dang ^a   Thuy, Le Thi Thanh ^a   The, Nguyen Duy ^a   Duy, Dinh Ngoc ^b   Dai, Bui ^c   Thanh, Nguyen Xuan ^c   Chavchich, Marina ^d   Rieckmann, Karl H ^d   Edstein, Michael D ^d  

^a Military Hospital 175   (Viet Nam)

^b Central University Hospital 108   (Viet Nam)

^c Military Institute of Hygiene and Epidemiology   (Viet Nam)

^d AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

Artesunate; Chloroquine; Malaria; Plasmodium vivax; Primaquine; Viet Nam

Indexed keywords

ARTESUNATE; PRIMAQUINE;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; DIARRHEA; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MALARIA; MALE; NAUSEA; NONHUMAN; PARASITEMIA; PATIENT COMPLIANCE; PLASMODIUM VIVAX; RELAPSE; SHORT COURSE THERAPY; SOUTHEAST ASIA; VIET NAM; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, VIVAX; MALE; PRIMAQUINE; RECURRENCE; SESQUITERPENES;

ARTESUNATE; PLASMODIUM VIVAX;

EID: 34247254411     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.01.003     Document Type: Article

References (30)

1. Baird J.K., and Rieckmann K.H. Can primaquine therapy for vivax malaria be improved?. Trends Parasitol. 3 (2003) 115-120
2. Baird J.K., Basri H., Purnomo, Bangs M.J., Subianto B., Patchen L.C., and Hoffman S.L. Resistance to chloroquine by Plasmodum vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44 (1991) 547-552
3. Baird J.K., Leksana B., Masbar S., Fryauff D.J., Sutanihardja M.A., Suradi, Wignall F.S., and Hoffman S.L. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 56 (1997) 621-626
4. Black R.H. Results of the clinical use of primaquine for the eradication of relapsing vivax malaria of South West Pacific origin. A report to the Royal Australian College of Physicians. Aust. Ann. Med. 7 (1958) 259
5. Bunnag D., Viravan C., Looareesuwan S., Karbwang J., and Harinasuta T. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian. J. Trop. Med. Public Health. 22 (1991) 380-385
6. Bunnag D., Karbwang J., Thanavibul A., Chittamas S., Ratanapongse Y., Chalermrut K., Na-Bangchang K.N., and Harinasuta T. High dose primaquine in primaquine resistant vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 218-219
7. Clayman C.B., Arnold J., Hockwald R.S., Yount E.H., Edgcomb J.H., and Alving A.S. Toxicity of primaquine in Caucasians. JAMA 149 (1952) 1563-1568
8. Clyde D.F., and McCarthy V.E. Radical cure of Chesson strain vivax malaria in man by 7, not 14 days of treatment with primaquine. Am. J. Trop. Med. Hyg. 26 (1977) 562-563
9. Collins W.E., and Jeffery G.M. Primaquine resistance in Plasmodium vivax. Am. J. Trop. Med. Hyg. 55 (1996) 243-249
10. Cooper W.C., Myatt A.V., Hernande Z.T., Jeffery G.M., and Coatney G.R. Studies in human malaria. XXXI. Comparison of primaquine, isopentaquine, SN-3883, and pamaquine as curative agents against Chesson strain vivax malaria. Am. J. Trop. Med. Hyg. 2 (1953) 949-957
11. Doherty J.F., Day J.H., Warhurst D.C., and Chiodini P.L. Treatment of Plasmodium vivax malaria-time for a change?. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 76
12. Duarte E.C., Pang L.W., Ribeiro L.C., and Fontes C.J.F. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am. J. Trop. Med. Hyg. 65 (2001) 471-476
13. Garg M., Gopinathan N., Bodhe P., and Kshirsagar N.A. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 656-657
14. Looareesuwan S., Buchachart K., Wilairatana P., Chalermrut K., Rattanapong Y., Amradee S., Siripiphat S., Chullawichit S., Thimasan K., Ittiverakul M., Triampon A., and Walsh D.S. Primaquine-tolerant vivax malaria in Thailand. Ann. Trop. Med. Parasitol. 91 (1997) 939-943
15. Looareesuwan S., Wilairatana P., Glanarongran R., Indravijit K.A., Supeeranontha L., Chinnapha S., Scott T.R., and Chulay J.D. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93 (1999) 637-640
16. Mendis K., Sina B.J., Marchesini P., and Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64 (2001) 97-106
17. Mihaly G.W., Ward S.A., Edwards G., Orme M.LE., and Breckenridge A.M. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br. J. Clin. Pharmacol. 17 (1984) 441-446
18. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, Nwe-Nwe-Yin 1993. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 87, 687.
19. Nasveld P.E., Kitchener S., Edstein M.D., and Rieckmann K.H. Comparison of tafenoquine (WR238605) and primaquine in the post exposure prophylaxis of vivax malaria in Australian Defence Force personnel. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 683-684
20. Padley D., Moody A.H., Chiodini P.L., and Saldanha J. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann. Trop. Med. Parasitol. 97 (2003) 131-137
21. Phan G.T., de Vries P.J., Tran B.Q., Le H.Q., Nguyen N.V., Nguyen T.V., Heisterkamp S.H., and Kager P.A. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop. Med. Int. Health 7 (2002) 858-864
22. Price R., van Vugt M., Phaipun L., Luxemburger C., Simpson J., McGready R., ter Kuile F., Kham A., Chongsuphajaisiddhi T., White N.J., and Nosten F. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am. J. Trop. Med. Hyg. 60 (1999) 547-555
23. Pukrittayakamee S., Vanijanonta S., Chantra A., Clemens R., and White N.J. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J. Infect. Dis. 169 (1994) 932-935
24. Pukrittayakamee S., Chantra A., Simpson J.A., Vanijanonta S., Clemens R., Looareesuwan S., and White N.J. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44 (2000) 1680-1685
25. Rieckmann K.H., Davis D.R., and Hutton D.C. Plasmodium vivax resistance to chloroquine?. Lancet 2 (1989) 1183-1184
26. Rieckmann K.H., Yeo A.E.T., Davis D.R., and Hutton D.C. Recent military experience with malaria chemoprophylaxis. Med. J. Aust. 158 (1993) 446-449
27. Schmidt L.H., Fradkin R., Vaughan D., and Rasco J. Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose. Am. J. Trop. Med. Hyg. 26 (1977) 1116-1128
28. Silachamroon U., Krudsood S., Treeprasertsuk S., Wilairatana P., Chalearmrult K., Mint H.Y., Maneekan P., White N.J., Gourdeuk V.R., Brittenham G.M., and Looareesuwan S. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 69 (2003) 14-18
29. White N.J. The assessment of antimalarial drug efficacy. Trends Parasitol. 18 (2002) 458-464
30. WHO. Malaria, Chapter 7: in: International Travel and Health (2005), World Health Organization, Geneva. http://www.who.int/ith/en/ http://www.who.int/ith/en/ [accessed January 2007]